S16 Ep24: Tumor Board: Translating HER2 and TROP2 Innovations to Transform NSCLC Care
Highlights from the PER® CME activity "Tumor Board: Translating HER2 and TROP2 Innovations to Transform NSCLC Care" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.
In this podcast, experts Jacob Sands, MD; Marina Chiara Garassino, MD; and Eric Singhi, MD; use realistic cases to explore key decision points in applying HER2- and TROP2-targeted therapies across the non–small cell lung cancer (NSCLC) continuum, including patient selection, sequencing, and toxicity management.
Earn CME credit by completing the full…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.